source
- Lycia Therapeutics targets $228M IPO to fund food allergy protein degrader programsLycia Therapeutics announced plans for an initial public offering expected to raise about $228 million. The proceeds are intended to support its pipeline of protein degrader therapeutics targeting…
- FDA and UK regulators discuss new frameworks for generative AI oversightAt the MedTech Conference in Boston, officials from the U.S. Food and Drug Administration and the U.K. Medicines and Healthcare products Regulatory Agency met to talk about how to regulate generati…